dual PPAR alpha/delta antagonists (Inception Therapeutics)

N/A

Report date: 2025/03/18 18:12:13
NME

Base Information

Drug Namedual PPAR alpha/delta antagonists (Inception Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α inhibitorsPeroxisome proliferator-activated receptor delta inhibitors
TargetsPeroxisome proliferator-activated receptor αPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInception Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesInception Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A